DOI:
10.1055/s-00000031
Klinische Monatsblätter für Augenheilkunde
LinksClose Window
References
Ziemssen F, Cruess A, Dunger-Baldauf C. et al.
Ranibizumab in diabetic macular oedema–a benefit–risk analysis of ranibizumab 0.5 mg PRN versus laser treatment.
Eur Endocrinol 2017;
13: 91
Access:
We do not assume any responsibility for the contents of the web pages of other providers.